These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 11166453
1. Interleukin-6 and the soluble interleukin-6 receptor induce stem cell factor and Flt-3L expression in vivo and in vitro. Peters M, Solem F, Goldschmidt J, Schirmacher P, Rose-John S. Exp Hematol; 2001 Feb; 29(2):146-55. PubMed ID: 11166453 [Abstract] [Full Text] [Related]
2. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling. Sui X, Tsuji K, Ebihara Y, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T, Nakahata T. Blood; 1999 Apr 15; 93(8):2525-32. PubMed ID: 10194431 [Abstract] [Full Text] [Related]
3. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells]. Feng JF, Zhuang M, Zhu LJ, Sheng ZL, Zhu YQ, Li CP. Ai Zheng; 2004 Jun 15; 23(6):715-8. PubMed ID: 15191679 [Abstract] [Full Text] [Related]
4. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Schirmacher P, Peters M, Ciliberto G, Blessing M, Lotz J, Meyer zum Büschenfelde KH, Rose-John S. Am J Pathol; 1998 Aug 15; 153(2):639-48. PubMed ID: 9708822 [Abstract] [Full Text] [Related]
5. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Fattori E, Ciliberto G, Dienes HP, Meyer zum Büschenfelde KH, Rose-John S. J Exp Med; 1997 Feb 17; 185(4):755-66. PubMed ID: 9034153 [Abstract] [Full Text] [Related]
6. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors. Kimura T, Wang J, Minamiguchi H, Fujiki H, Harada S, Okuda K, Kaneko H, Yokota S, Yasukawa K, Abe T, Sonoda Y. Stem Cells; 2000 Feb 17; 18(6):444-52. PubMed ID: 11072033 [Abstract] [Full Text] [Related]
7. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. Tajima S, Tsuji K, Ebihara Y, Sui X, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T, Nakahata T. J Exp Med; 1996 Oct 01; 184(4):1357-64. PubMed ID: 8879208 [Abstract] [Full Text] [Related]
8. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T. Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2859-63. PubMed ID: 7535932 [Abstract] [Full Text] [Related]
9. Serum soluble IL-6 receptor levels during the mobilization of stem cells to peripheral blood. Omura H, Kawatani T, Tajima F, Ishiga K, Ohmura H, Kawasaki H, Nanba E. Leuk Lymphoma; 2002 Mar 28; 43(3):623-30. PubMed ID: 12002769 [Abstract] [Full Text] [Related]
10. Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells. Nakahata T, Sui X, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Tsuji K. Cancer Chemother Pharmacol; 1996 Mar 28; 38 Suppl():S64-8. PubMed ID: 8765420 [Abstract] [Full Text] [Related]
11. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, Wilkinson TS, Yamamoto N, Topley N, Jones SA. J Immunol; 2004 May 01; 172(9):5676-83. PubMed ID: 15100312 [Abstract] [Full Text] [Related]
12. The soluble form of interleukin-6 receptor modulates cell proliferation by acute myeloblastic leukemia blast cells. Säily M, Koistinen P, Savolainen ER. Ann Hematol; 1999 Apr 01; 78(4):173-9. PubMed ID: 10348148 [Abstract] [Full Text] [Related]
13. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T. J Clin Invest; 2000 Apr 01; 105(7):1013-21. PubMed ID: 10749580 [Abstract] [Full Text] [Related]
18. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. Chebath J, Fischer D, Kumar A, Oh JW, Kolett O, Lapidot T, Fischer M, Rose-John S, Nagler A, Slavin S, Revel M. Eur Cytokine Netw; 1997 Dec 01; 8(4):359-65. PubMed ID: 9459615 [Abstract] [Full Text] [Related]
19. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. Cho SW, Pirih FQ, Koh AJ, Michalski M, Eber MR, Ritchie K, Sinder B, Oh S, Al-Dujaili SA, Lee J, Kozloff K, Danciu T, Wronski TJ, McCauley LK. J Biol Chem; 2013 Mar 08; 288(10):6814-25. PubMed ID: 23297399 [Abstract] [Full Text] [Related]
20. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Coletta I, Soldo L, Polentarutti N, Mancini F, Guglielmotti A, Pinza M, Mantovani A, Milanese C. Exp Nephrol; 2000 Mar 08; 8(1):37-43. PubMed ID: 10644881 [Abstract] [Full Text] [Related] Page: [Next] [New Search]